Latest Breaking News On - Celia economides - Page 1 : comparemela.com

Gritstone bio, Inc (NASDAQ:GRTS) Q1 2024 Earnings Call Transcript

Gritstone bio, Inc (NASDAQ:GRTS) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Karin joossJon millerAndrew allenGeorge macdougallChengxiang liuSteven rosenbergMarc frahmCelia economidesCorporate communications at gritstoneExchange commissionNational cancer institutesGritstone bio incRecreation services stocks toGilead sciencesCall transcript mayFirst quarter

Gritstone bio, Inc (NASDAQ:GRTS) Q1 2023 Earnings Call Transcript

Operator: My name is Erika and welcome to Gritstone bio First Quarter 2023 Earnings Conference Call. Please note this event is being recorded.

United statesWhite houseDistrict of columbiaSloan ketteringJonathan millerMayank mamtaniTed tenthoffCelia economidesSean leeVinod balachandranMarc frahmCorinne jenkinsAndrew allenPiper sandlerGeorge macdougallSilicon valley bank

Vial CEO and Co-Founder, Simon Burns to Speak at the BIO CEO & Investor Conference in New York

/PRNewswire/ Vial, a global tech-enabled CRO providing next-generation clinical trial management services, announced its CEO and Co-Founder, Simon Burns,.

New yorkUnited statesSan franciscoEvan lohMarriott marquisCraig lipsetCelia economidesSimon burnsParatek pharmaErnst youngResearch allianceSparse funding periodSouth broadway ballroomNew york marriottArda uralClinical innovation partner

Gritstone bio to Participate in Upcoming Investor

EMERYVILLE, Calif., Jan. 18, 2023 (GLOBE NEWSWIRE) Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the.

Andrew allenDan budwickCelia economidesGeorgee macdougallPanel titleInvestor conference panelInvestor relations corporate communicationsAnnual oncology conferenceFireside chatChief executiveChief financialGlobal biopharma conferenceInvestor relationsNasdaq grtsGritstone bio

Gritstone to Participate in Two Upcoming Investor Conferences

01.09.2022 - EMERYVILLE, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) - Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today announced that management will present at the 2022 Wells .

New yorkUnited statesMatthewj hawrylukCelia economidesFargo healthcare conferenceAnnual global investment conferenceFargo healthcareChief financial officerChief business